VSEE HEALTH, INC. (VSEEW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 1.5M 3M 4.5M Q1 '23: 1.6M Q2 '23: 1.3M Q3 '23: 1.5M Q4 '23: 1.5M Q1 '24: 1.6M Q2 '24: 1.7M Q3 '24: 3.4M Q4 '24: 3.7M Q1 '25: 3.3M Q2 '25: 1.1M Q3 '25: 4M Q4 '25: 3.9M Q1 '26: 3.2M Q2 '26: 1.6M Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit Quarterly

0 1M 2M 3M Q1 '23: 1M Q2 '23: 815.9K Q3 '23: 973.1K Q4 '23: 1.1M Q1 '24: 1.2M Q2 '24: 777K Q3 '24: 2.8M Q4 '24: 2.4M Q1 '25: 1.9M Q2 '25: 615K Q3 '25: 2.1M Q4 '25: 1.8M Q1 '26: 1.2M Q2 '26: 206.2K Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q2 '21: -5K Q3 '21: -180 Q1 '22: -543.2K Q2 '22: -722.2K Q3 '22: -1.1M Q4 '22: -1.2M Q1 '23: -707.6K Q2 '23: -611.1K Q3 '23: -274.4K Q4 '23: -114.8K Q1 '24: 104.1K Q2 '24: -932.5K Q3 '24: -58.3M Q4 '24: -3M Q1 '25: -1.8M Q2 '25: -1.6M Q3 '25: -2.1M Q4 '25: -3.4M Q1 '26: -3M Q2 '26: -2.7M Q3 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q2 '21: -5K Q3 '21: -180 Q1 '22: -527.4K Q2 '22: -659.5K Q3 '22: -820.8K Q4 '22: -1.2M Q1 '23: -451.3K Q2 '23: -424.6K Q3 '23: -111K Q4 '23: -2.5M Q1 '24: 62.8K Q2 '24: -634.1K Q3 '24: -53.9M Q4 '24: -3.2M Q1 '25: -4M Q2 '25: -2.6M Q3 '25: -289.7K Q4 '25: -7.9M Q1 '26: -2.6M Q2 '26: -1.7M Q3 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 800K 1.6M 2.4M Q2 '23: 474.3K Q3 '23: 478.4K Q1 '24: 386.3K Q2 '24: 934.6K Q3 '24: 569.7K Q4 '24: 1.4M Q1 '25: 1.5M Q2 '25: 440.1K Q3 '25: 1.9M Q4 '25: 2.1M Q1 '26: 2M Q2 '26: 1.4M Q3 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q1 '22: -250.3K Q2 '22: -318.6K Q3 '22: -146.2K Q4 '22: -676.2K Q1 '23: -340.7K Q2 '23: -134K Q3 '23: -48.8K Q4 '23: -109.2K Q1 '24: 579.3K Q2 '24: -3.2M Q3 '24: -221K Q4 '24: -3M Q1 '25: -440.5K Q2 '25: -324.6K Q3 '25: -754.5K Q4 '25: -1.9M Q1 '26: -2.5M Q2 '26: -1.2M Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '23: -48.8K Q4 '23: -110.8K Q1 '24: 570.5K Q2 '24: -3.2M Q3 '24: -226K Q4 '24: -3M Q1 '25: -452.4K Q2 '25: -336.5K Q3 '25: -777.3K Q4 '25: -1.9M Q1 '26: -2.5M Q2 '26: -1.2M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '22: 14.9M Q2 '22: 14.9M Q3 '22: 14.9M Q1 '23: 4.2M Q2 '23: 4.6M Q3 '23: 10M Q1 '24: 4.6M Q2 '24: 5.3M Q3 '24: 15.1M Q1 '25: 16.3M Q2 '25: 16.4M Q3 '25: 16.5M Q1 '26: 47.9M Q2 '26: 53.7M Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '22: -0.25 Q1 '24: -0.35 Q2 '24: -0.38 Q3 '24: -3.95 Q4 '25: -0.73 Q1 '26: -0.54 Q4 '22 Q1 '24 Q2 '24 Q3 '24 Q4 '25 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.